We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+16.76%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.4B
AUM Growth
-$147M
Cap. Flow
-$283M
Cap. Flow %
-11.81%
Top 10 Hldgs %
28.1%
Holding
209
New
22
Increased
53
Reduced
105
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 29.57%
2 Industrials 16.81%
3 Healthcare 15.75%
4 Financials 10.45%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTAI icon
76
FTAI Aviation
FTAI
$22.6B
$8.47M 0.35%
+58,790
New +$8.67M
EWTX icon
77
Edgewise Therapeutics
EWTX
$4.9B
$8.01M 0.33%
300,013
-211,892
-41% -$6.75M
NCLH icon
78
Norwegian Cruise Line
NCLH
$8.57B
$7.63M 0.32%
+296,707
New +$7.5M
LOVE
79
LoveSac
LOVE
$258M
$7.58M 0.32%
320,558
-156,300
-33% -$4.68M
GTLS
80
DELISTED
Chart Industries
GTLS
$7.5M 0.31%
39,289
-159,122
-80% -$25.6M
PTC icon
81
PTC
PTC
$16.3B
$7.5M 0.31%
40,766
-16,660
-29% -$3.16M
COCO icon
82
Vita Coco
COCO
$3.67B
$7.47M 0.31%
202,419
-454,013
-69% -$15.1M
MLTX icon
83
MoonLake Immunotherapeutics
MLTX
$1.37B
$7.39M 0.31%
136,438
-36,196
-21% -$1.85M
PRO
84
DELISTED
PROS Holdings
PRO
$7.34M 0.31%
334,355
-174,226
-34% -$3.75M
FROG icon
85
JFrog
FROG
$10.5B
$7.18M 0.3%
244,057
-76,768
-24% -$2.33M
XENE icon
86
Xenon Pharmaceuticals
XENE
$6.19B
$7.15M 0.3%
182,333
-18,544
-9% -$767K
LSCC icon
87
Lattice Semiconductor
LSCC
$18.1B
$7.08M 0.3%
124,941
+29,015
+30% +$1.59M
PLRX icon
88
Pliant Therapeutics
PLRX
$65.6M
$6.94M 0.29%
527,147
-211,105
-29% -$2.88M
QLYS icon
89
Qualys
QLYS
$6.42B
$6.67M 0.28%
47,549
-28,501
-37% -$3.97M
FIVN icon
90
FIVE9
FIVN
$2.54B
$6.65M 0.28%
163,657
-39,789
-20% -$1.44M
VECO icon
91
Veeco
VECO
$3.05B
$6.53M 0.27%
243,669
-48,095
-16% -$1.4M
STOK icon
92
Stoke Therapeutics
STOK
$2.08B
$6.26M 0.26%
567,689
-77,281
-12% -$949K
VRNS icon
93
Varonis Systems
VRNS
$4.86B
$6.09M 0.25%
137,005
-9,227
-6% -$480K
CCC
94
CCC Intelligent Solutions
CCC
$4.08B
$6.07M 0.25%
517,180
-90,806
-15% -$1.05M
CRVL icon
95
CorVel
CRVL
$3.1B
$6.05M 0.25%
54,366
-17,067
-24% -$1.91M
ZYME icon
96
Zymeworks
ZYME
$1.74B
$6.02M 0.25%
411,120
-202,383
-33% -$2.83M
ITCI
97
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5.83M 0.24%
69,841
-29,693
-30% -$2.44M
SLAB icon
98
Silicon Laboratories
SLAB
$7.22B
$5.77M 0.24%
46,463
-12,130
-21% -$1.39M
VITL icon
99
Vital Farms
VITL
$501M
$5.7M 0.24%
151,347
+51,942
+52% +$1.85M
QTRX icon
100
Quanterix
QTRX
$114M
$5.7M 0.24%
536,417
-566,214
-51% -$6.89M

Similar funds

Granahan Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Granahan Investment Management held 209 positions worth $2.4B, down 5.8% from $2.54B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Granahan Investment Management withdrew a net $283M in Q4 2024, closing 29 positions and reducing 105 holdings. Its most notable exit was Smartsheet Inc., an estimated $33.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Granahan Investment Management opened a new position in KinderCare Learning Companies worth $25.7M.

  • Granahan Investment Management's largest Q4 2024 buy was KinderCare Learning Companies: 1,446,059 shares worth $25.7M.
  • Granahan Investment Management added most to Marex Group Limited Ordinary Shares in Q4 2024, an estimated $26.8M increase.
  • Granahan Investment Management's biggest Q4 2024 reduction was Zeta Global, cutting an estimated $55.8M.
  • Granahan Investment Management fully exited Smartsheet Inc. in Q4 2024, selling an estimated $33.3M.
  • Granahan Investment Management's ten largest holdings make up 28% of its $2.4B portfolio in Q4 2024.
  • Granahan Investment Management opened 22 new positions and closed 29 in Q4 2024.
  • Granahan Investment Management's portfolio value fell 5.8% quarter-over-quarter to $2.4B.

Based on Granahan Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.